Results for "cardiovascular disease"
Heart Disease
** Heart disease, encompassing a broad spectrum of cardiovascular conditions, remains the world’s leading health challenge, affecting millions and shaping modern medicine’s most urgent priorities. **CONTENT:** ## Overview **Heart disease**—more formally known as **cardiovascular disease (CVD)**—refers to any disorder that involves the heart or the blood vessels that circulate blood throughout the body. This umbrella term covers a diverse array of conditions, from **coronary artery disease** that narrows the arteries supplying the heart muscle, to **heart failure** where the heart cannot pump efficiently, to **arrhythmias** that disrupt the heart’s rhythm. Because the circulatory system is essential for delivering oxygen and nutrients to every organ, any impairment can have cascading effects on overall health. The global burden of CVD is staggering: it is the foremost cause of death worldwide, outpacing infectious diseases and cancers combined. The sheer variety of diseases—ranging from **hypertensive heart disease** linked to chronic high blood pressure, to **rheumatic heart disease** that follows untreated streptococcal infections, to **congenital heart defects** present from birth—means that prevention, diagnosis, and treatment require a multidisciplinary approach. Modern cardiology has evolved from simple stethoscope examinations to sophisticated imaging, minimally invasive interventions, and personalized pharmacotherapy, all aimed at reducing the morbidity and mortality associated with heart disease. ## Background & Origins The concept of heart disease dates back to ancient medical texts, where early physicians described “hardness of the heart” and “blocked vessels” in vague terms. However, the systematic classification of cardiovascular conditions emerged only with the advent of modern anatomy and pathology in the 17th and 18th centuries. Pioneering anatomists began to differentiate between diseases of the heart muscle, the valves, and the blood vessels, laying the groundwork for today’s comprehensive definition of CVD. The term **cardiovascular disease** itself was coined in the 20th century as researchers recognized that many seemingly distinct ailments shared common pathophysiological pathways—most notably atherosclerosis, the buildup of fatty plaques within arterial walls. This insight unified disparate conditions under a single conceptual framework, prompting large‑scale epidemiological studies that identified lifestyle factors (such as diet, tobacco use, and physical inactivity) as major contributors to disease risk. ## Major Achievements & Milestones **Recognition of CVD as a leading public‑health priority** (Year unknown): International health organizations formally identified cardiovascular disease as the top cause of death, spurring global initiatives for prevention and research. **Development of coronary artery bypass grafting (CABG)** (Year unknown): Surgeons introduced a surgical technique that reroutes blood around blocked coronary arteries, dramatically improving survival for patients with severe coronary artery disease. **Introduction of statin therapy** (Year unknown): The discovery that cholesterol‑lowering drugs could reduce plaque formation transformed the medical management of atherosclerosis, offering a preventive tool for millions at risk. ## Timeline - **Year unknown**: Early anatomical descriptions of heart and vessel disease appear in medical manuscripts. - **Year unknown**: The term “cardiovascular disease” is adopted to unify heart‑ and vessel‑related conditions. - **Year unknown**: First successful coronary artery bypass surgery performed, establishing a new therapeutic cornerstone. - **Year unknown**: Statins enter clinical practice, providing a pharmacologic means to combat atherosclerosis. ## Impact & Legacy Heart disease’s impact extends far beyond the clinic. Economically, the costs of treating CVD—including hospitalizations, surgeries, and long‑term medication—represent a substantial portion of national healthcare expenditures. Socially, families and communities bear the emotional toll of chronic illness and premature loss. Culturally, heart disease has shaped public awareness campaigns, from “Go Red for Women” to worldwide “World Heart Day,” emphasizing that heart health is a shared responsibility. Scientifically, the study of CVD has driven innovations in imaging (e.g., echocardiography, cardiac MRI), biomarker discovery (troponins, natriuretic peptides), and minimally invasive procedures (angioplasty, transcatheter valve replacement). These advances have not only improved outcomes for heart patients but have also spilled over into other fields, such as oncology and neurology, where vascular health is equally critical. ## Records & Notable Facts - **CVD is the single largest cause of death globally**, surpassing all other disease categories combined. - **More than half of all cardiovascular deaths occur in low‑ and middle‑income countries**, highlighting disparities in access to care and preventive resources. - **Heart disease can affect anyone**, regardless of age, gender, or ethnicity, though risk profiles differ across populations. > “The heart is the engine of life; when it falters, the whole organism suffers.” **INFOBOX:** - Full Name: Cardiovascular Disease (CVD) - Born: N/A (concept emerged over centuries) - Died: Living - Age: N/A - Nationality: Global (affects all populations) - Occupation: Medical classification encompassing heart and blood‑vessel disorders - Active Years: Pre‑modern era‑present - Known For: Encompassing coronary artery disease, heart failure, arrhythmia, and more - Awards: N/A (medical classification) - Spouse: N/A - Children: N/A - Height: N/A - Net Worth: N/A - World Records: N/A - Championships: N/A **FACTS:** - Birth Date: N/A (type: date) - Birth Place: N/A (type: location) - Death Date: N/A (type: date) - Career Start: N/A (type: year) - Peak Achievement: Global recognition as leading cause of death (type: achievement) - Career Earnings: N/A (type: statistic) - World Record: N/A (type: record) - Famous Quote: “The heart is the engine of life; when it falters, the whole organism suffers.” (type: quote) - Fun Fact: More than half of cardiovascular deaths occur in low‑ and middle‑income nations (type: trivia) - Legacy Stat: CVD accounts for the highest proportion of global mortality (type: statistic) **TAGS:** heart disease, cardiovascular disease, cardiology, public health, epidemiology, prevention, treatment, global health *This article is for educational purposes only. Always consult qualified healthcare professionals for diagnosis, treatment, and personalized medical advice.*
Health & MedicineCholesterol Dietary
** Dietary cholesterol refers to the cholesterol found in animal‑derived foods and its influence on blood cholesterol levels, heart health, and overall nutrition. **CONTENT:** ## Overview **Dietary cholesterol** is a lipophilic molecule present in animal products such as eggs, meat, dairy, and shellfish. Unlike plant sterols, which are called phytosterols, cholesterol is synthesized by virtually all animal cells and plays essential roles in membrane structure, hormone production, and bile‑acid synthesis. For decades, nutrition science has debated how much cholesterol consumed in the diet directly raises **serum low‑density lipoprotein (LDL)**, the “bad” cholesterol linked to atherosclerotic cardiovascular disease (ASCVD). Modern research shows that, for most people, dietary cholesterol has a modest effect on blood cholesterol because the liver can adjust its own cholesterol synthesis. However, individuals termed **“hyper‑responders”** may experience a more pronounced rise in LDL and total cholesterol when they ingest large amounts of cholesterol‑rich foods. Moreover, the overall dietary pattern—particularly saturated fat intake, fiber content, and the presence of plant sterols—modulates the impact of dietary cholesterol on cardiovascular risk. Health professionals advise that the **quality of the diet** matters more than a single nutrient count. Replacing saturated fats with unsaturated fats, increasing soluble fiber, and consuming a variety of fruits, vegetables, whole grains, and legumes can mitigate any potential adverse effects of dietary cholesterol. People with existing heart disease, diabetes, or familial hypercholesterolemia should consult a physician or registered dietitian before making major changes to cholesterol‑rich food intake. ## History/Background The relationship between diet and heart disease entered mainstream awareness in the 1950s with Ancel Keys’ **“Seven Countries Study,”** which linked high saturated fat intake to elevated serum cholesterol and coronary heart disease. Early dietary guidelines, such as the 1968 U.S. Dietary Guidelines for Americans, placed a **limit of 300 mg of cholesterol per day**, reflecting the prevailing belief that dietary cholesterol directly caused high blood cholesterol. In the 1990s, the **Framingham Heart Study** and subsequent meta‑analyses revealed that the correlation was weaker than previously thought, especially when saturated fat intake was low. By 2015, the **U.S. Dietary Guidelines Advisory Committee** removed the specific cholesterol limit, emphasizing overall dietary patterns instead. Nevertheless, research continued to refine the picture: the 2019 **American Heart Association (AHA) Scientific Statement** acknowledged that while most people can consume up to one egg per day without increasing ASCVD risk, certain sub‑populations (e.g., diabetics) may need stricter monitoring. ## Key Information - **Sources:** Eggs (≈186 mg per large egg), shrimp (≈150 mg per 100 g), liver, cheese, and full‑fat dairy are the richest sources. Plant foods contain negligible cholesterol. - **Absorption:** About 50‑60 % of dietary cholesterol is absorbed in the small intestine; this rate can be reduced by dietary fiber and plant sterols. - **Regulation:** The liver compensates for dietary intake by down‑regulating endogenous synthesis via the **HMG‑CoA reductase** pathway. Statin medications target this same enzyme. - **Hyper‑responders:** Approximately 15‑25 % of the population exhibit a >10 % rise in LDL when dietary cholesterol exceeds 300 mg/day. Genetic factors (e.g., variants in **ABCG5/8** transporters) influence this response. - **Guidelines:** Current recommendations focus on **limiting saturated fat to <10 % of total calories**, increasing **soluble fiber (5–10 g/day)**, and choosing **lean protein** sources. For most adults, moderate egg consumption (1‑3 per week) is considered safe. - **Clinical considerations:** Patients with **familial hypercholesterolemia**, uncontrolled diabetes, or established ASCVD should discuss dietary cholesterol with a healthcare provider, as individualized limits may be warranted. ## Significance Understanding dietary cholesterol is crucial because it informs public health policies, food labeling, and individual dietary counseling. The shift from a cholesterol‑centric view to a **holistic dietary pattern** approach has reduced unnecessary dietary restrictions, allowing people to enjoy nutrient‑dense foods like eggs without fear of automatically raising heart disease risk. This evolution also underscores the importance of **evidence‑based nutrition**, where recommendations adapt as high‑quality randomized controlled trials and large cohort studies emerge. The legacy of dietary cholesterol research lies in its demonstration of the body’s **homeostatic mechanisms** and the need to consider **gene‑environment interactions**. It has spurred development of functional foods enriched with plant sterols, and it continues to guide clinicians in tailoring advice for patients with specific metabolic profiles. Ultimately, balanced consumption of cholesterol‑containing foods, within a diet low in saturated fat and high in fiber, supports cardiovascular health while preserving the nutritional benefits of these foods—such as high‑quality protein, vitamins (e.g., B12, D), and minerals (e.g., selenium). **When to seek professional care:** If you have a personal or family history of heart disease, high blood cholesterol, diabetes, or you experience unexplained changes in lipid panels after altering your diet, consult a physician or registered dietitian. They can provide personalized guidance, order appropriate blood tests, and, if needed, prescribe lipid‑lowering therapy. **INFOBOX:** - Name: Dietary Cholesterol - Type: Nutrient (lipid) - Date: First identified in 19th‑century biochemistry; major dietary guidelines revised 2015‑2023 - Location: Present in animal‑derived foods worldwide - Known For: Influencing serum cholesterol levels and shaping modern nutrition policy **TAGS:** cholesterol, diet, cardiovascular disease, nutrition guidelines, lipid metabolism, hyper‑responders, dietary fats, public health**SUMMARY:** Dietary cholesterol refers to the cholesterol found in animal‑derived foods and its influence on blood cholesterol levels, heart health, and overall nutrition. **CONTENT:** ## Overview **Dietary cholesterol** is a lipophilic molecule present in animal products such as eggs, meat, dairy, and shellfish. Unlike plant sterols, which are called phytosterols, cholesterol is synthesized by virtually all animal cells and plays essential roles in membrane structure, hormone production, and bile‑acid synthesis. For decades, nutrition science has debated how much cholesterol consumed in the diet directly raises **serum low‑density lipoprotein (LDL)**, the “bad” cholesterol linked to atherosclerotic cardiovascular disease (ASCVD). Modern research shows that, for most people, dietary cholesterol has a modest effect on blood cholesterol because the liver can adjust its own cholesterol synthesis. However, individuals termed **“hyper‑responders”** may experience a more pronounced rise in LDL and total cholesterol when they ingest large amounts of cholesterol‑rich foods. Moreover, the overall dietary pattern—particularly saturated fat intake, fiber content, and the presence of plant sterols—modulates the impact of dietary cholesterol on cardiovascular risk. Health professionals advise that the **quality of the diet** matters more than a single nutrient count. Replacing saturated fats with unsaturated fats, increasing soluble fiber, and consuming a variety of fruits, vegetables, whole grains, and legumes can mitigate any potential adverse effects of dietary cholesterol. People with existing heart disease, diabetes, or familial hypercholesterolemia should consult a physician or registered dietitian before making major changes to cholesterol‑rich food intake. ## History/Background The relationship between diet and heart disease entered mainstream awareness in the 1950s with Ancel Keys’ **“Seven Countries Study,”** which linked high saturated fat intake to elevated serum cholesterol and coronary heart disease. Early dietary guidelines, such as the 1968 U.S. Dietary Guidelines for Americans, placed a **limit of 300 mg of cholesterol per day**, reflecting the prevailing belief that dietary cholesterol directly caused high blood cholesterol. In the 1990s, the **Framingham Heart Study** and subsequent meta‑analyses revealed that the correlation was weaker than previously thought, especially when saturated fat intake was low. By 2015, the **U.S. Dietary Guidelines Advisory Committee** removed the specific cholesterol limit, emphasizing overall dietary patterns instead. Nevertheless, research continued to refine the picture: the 2019 **American Heart Association (AHA) Scientific Statement** acknowledged that while most people can consume up to one egg per day without increasing ASCVD risk, certain sub‑populations (e.g., diabetics) may need stricter monitoring. ## Key Information - **Sources:** Eggs (≈186 mg per large egg), shrimp (≈150 mg per 100 g), liver, cheese, and full‑fat dairy are the richest sources. Plant foods contain negligible cholesterol. - **Absorption:** About 50‑60 % of dietary cholesterol is absorbed in the small intestine; this rate can be reduced by dietary fiber and plant sterols. - **Regulation:** The liver compensates for dietary intake by down‑regulating endogenous synthesis via the **HMG‑CoA reductase** pathway. Statin medications target this same enzyme. - **Hyper‑responders:** Approximately 15‑25 % of the population exhibit a >10 % rise in LDL when dietary cholesterol exceeds 300 mg/day. Genetic factors (e.g., variants in **ABCG5/8** transporters) influence this response. - **Guidelines:** Current recommendations focus on **limiting saturated fat to <10 % of total calories**, increasing **soluble fiber (5–10 g/day)**, and choosing **lean protein** sources. For most adults, moderate egg consumption (1‑3 per week) is considered safe. - **Clinical considerations:** Patients with **familial hypercholesterolemia**, uncontrolled diabetes, or established ASCVD should discuss dietary cholesterol with a healthcare provider, as individualized limits may be warranted. ## Significance Understanding dietary cholesterol is crucial because it informs public health policies, food labeling, and individual dietary counseling. The shift from a cholesterol‑centric view to a **holistic dietary pattern** approach has reduced unnecessary dietary restrictions, allowing people to enjoy nutrient‑dense foods like eggs without fear of automatically raising heart disease risk. This evolution also underscores the importance of **evidence‑based nutrition**, where recommendations adapt as high‑quality randomized controlled trials and large cohort studies emerge. The legacy of dietary cholesterol research lies in its demonstration of the body’s **homeostatic mechanisms** and the need to consider **gene‑environment interactions**. It has spurred development of functional foods enriched with plant sterols, and it continues to guide clinicians in tailoring advice for patients with specific metabolic profiles. Ultimately, balanced consumption of cholesterol‑containing foods, within a diet low in saturated fat and high in fiber, supports cardiovascular health while preserving the nutritional benefits of these foods—such as high‑quality protein, vitamins (e.g., B12, D), and minerals (e.g., selenium). **When to seek professional care:** If you have a personal or family history of heart disease, high blood cholesterol, diabetes, or you experience unexplained changes in lipid panels after altering your diet, consult a physician or registered dietitian. They can provide personalized guidance, order appropriate blood tests, and, if needed, prescribe lipid‑lowering therapy. **INFOBOX:** - Name: Dietary Cholesterol - Type: Nutrient (lipid) - Date: First identified in 19th‑century biochemistry; major dietary guidelines revised 2015‑2023 - Location: Present in animal‑derived foods worldwide - Known For: Influencing serum cholesterol levels and shaping modern nutrition policy **TAGS:** cholesterol, diet, cardiovascular disease, nutrition guidelines, lipid metabolism, hyper‑responders, dietary fats, public health
Health & MedicineCoronary Artery Disease
Coronary artery disease (CAD) is a condition where the buildup of atheromatous plaque in the coronary arteries leads to reduced blood flow to the heart muscle, increasing the risk of heart attacks and other cardiovascular events. ## Overview Coronary artery disease (CAD) is a widespread and complex condition affecting millions worldwide. It involves the narrowing of the coronary arteries due to the accumulation of cholesterol-rich atheromatous plaque, which can lead to reduced blood flow to the heart muscle, causing various symptoms and potentially life-threatening complications. CAD is the most common cause of cardiovascular disease, responsible for a significant number of deaths and hospitalizations globally. CAD occurs when the walls of the coronary arteries become damaged, allowing low-density lipoprotein (LDL) cholesterol to accumulate and form atheromatous plaques. These plaques can rupture, triggering an inflammatory response that further damages the artery wall, leading to a blockage or significant narrowing of the coronary arteries. The reduced blood flow can cause a range of symptoms, from stable angina and myocardial ischemia to life-threatening myocardial infarctions (heart attacks). ## History/Background The concept of CAD dates back to the 19th century, when the French pathologist Claude Bernard first described the condition. However, it wasn't until the 1920s that the role of atherosclerosis in CAD became more widely recognized. The development of coronary angiography in the 1950s revolutionized the diagnosis and treatment of CAD, allowing doctors to visualize the coronary arteries and identify blockages. Since then, numerous advances in medical technology and our understanding of CAD have led to improved treatments and outcomes for patients. ## Key Information ### Risk Factors - **Hypertension**: High blood pressure is a significant risk factor for CAD, as it can cause damage to the coronary arteries and increase the risk of plaque buildup. - **High Cholesterol**: Elevated levels of LDL cholesterol can contribute to atheromatous plaque formation and increase the risk of CAD. - **Smoking**: Smoking is a well-established risk factor for CAD, as it damages the cardiovascular system and increases inflammation. - **Diabetes**: People with diabetes are at increased risk of CAD due to the damage caused by high blood sugar levels to the cardiovascular system. - **Family History**: A family history of CAD can increase an individual's risk of developing the condition. ### Symptoms and Complications - **Stable Angina**: A feeling of chest tightness or pressure that occurs when the heart muscle is not receiving enough oxygen. - **Unstable Angina**: A more severe and unpredictable form of angina that can indicate a greater risk of heart attack. - **Myocardial Ischemia**: A condition where the heart muscle is not receiving enough oxygen, which can lead to damage or death of heart tissue. - **Myocardial Infarction (Heart Attack)**: A life-threatening condition where the heart muscle is severely damaged due to a blockage in the coronary artery. ### Diagnosis and Treatment - **Coronary Angiography**: A test that uses X-rays to visualize the coronary arteries and identify blockages. - **Coronary Artery Bypass Grafting (CABG)**: A surgical procedure that involves bypassing blockages in the coronary arteries with a healthy graft. - **Percutaneous Coronary Intervention (PCI)**: A minimally invasive procedure that involves using a catheter to widen a narrowed coronary artery. - **Statins**: Medications that lower LDL cholesterol and reduce the risk of CAD. - **Aspirin**: A medication that helps prevent blood clots and reduces the risk of heart attack. ## Significance CAD is a widespread and complex condition that affects millions worldwide, resulting in significant morbidity and mortality. Understanding the risk factors, symptoms, and treatment options for CAD is crucial for preventing and managing the condition. Early detection and treatment can significantly reduce the risk of complications and improve outcomes for patients. INFOBOX: - Name: **Coronary Artery Disease** - Type: Cardiovascular Disease - Date: 19th century (first described by Claude Bernard) - Location: Global - Known For: Most common cause of cardiovascular disease and leading cause of death worldwide TAGS: Coronary artery disease, cardiovascular disease, atherosclerosis, heart attack, myocardial infarction, angina, hypertension, high cholesterol, smoking, diabetes, family history.
Health & MedicineStatins
** Statins are a class of lipid‑lowering drugs that inhibit HMG‑CoA reductase, reducing LDL cholesterol and lowering the risk of cardiovascular events in high‑risk individuals. **CONTENT:** ## Overview **Statins**, also known as HMG‑CoA reductase inhibitors, are the most widely prescribed medications for managing dyslipidemia. By blocking the enzyme HMG‑CoA reductase—the rate‑limiting step in hepatic cholesterol synthesis—statins decrease the production of cholesterol within the liver. This triggers up‑regulation of LDL receptors on hepatocyte surfaces, accelerating the clearance of low‑density lipoprotein (**LDL**) particles from the bloodstream. The net effect is a substantial reduction in circulating LDL‑cholesterol, the lipid fraction most strongly linked to atherosclerotic plaque formation. Clinically, statins are used for primary prevention (in people without known cardiovascular disease but with risk factors such as diabetes, hypertension, or a family history) and secondary prevention (in patients who have already experienced myocardial infarction, stroke, or peripheral arterial disease). The magnitude of benefit is dose‑dependent; high‑intensity regimens can lower LDL‑C by up to 55 %, while moderate‑intensity agents achieve reductions of 30‑50 %. In addition to lipid lowering, statins exert “pleiotropic” effects—anti‑inflammatory, endothelial‑protective, and plaque‑stabilizing actions—that further contribute to cardiovascular risk reduction. Patients should never start, stop, or adjust statin therapy without consulting a qualified health professional. Side effects, such as muscle pain (myalgia), elevated liver enzymes, or rare rhabdomyolysis, require medical evaluation. Individuals with a history of liver disease, pregnancy, or certain drug interactions need tailored counseling. ## History/Background The story of statins began in the 1950s when Japanese biochemist **Akira Endo** discovered that a fungus (*Penicillium citrinum*) produced a compound that inhibited HMG‑CoA reductase. This led to the isolation of **mevastatin** (compactin) in 1976, the first statin to enter clinical trials, though it was never marketed due to toxicity concerns. The breakthrough came in 1987 when **Merck & Co.** introduced **lovastatin**, the first commercially available statin, derived from *Aspergillus terreus*. In the 1990s, a new generation of synthetic statins—**simvastatin**, **pravastatin**, and **atorvastatin**—provided greater potency and improved pharmacokinetic profiles. Landmark trials such as the **Heart Protection Study (2002)** and **JUPITER (2008)** demonstrated that even modest LDL reductions translated into significant declines in myocardial infarction, stroke, and cardiovascular mortality. By the early 2010s, statins had become a cornerstone of global cardiovascular prevention guidelines, endorsed by the American Heart Association, European Society of Cardiology, and WHO. ## Key Information - **Mechanism of Action:** Inhibition of HMG‑CoA reductase → ↓ hepatic cholesterol synthesis → ↑ LDL‑receptor expression → ↓ plasma LDL‑C. - **Common Agents:** Lovastatin, Simvastatin, Pravastatin, Atorvastatin, Rosuvastatin, Fluvastatin, Pitavastatin. - **Dosing Intensity:** *Low‑intensity* (e.g., pravastatin 10‑20 mg) → ↓ LDL‑C 20‑30 %; *Moderate‑intensity* (e.g., atorvastatin 10‑20 mg) → ↓ LDL‑C 30‑50 %; *High‑intensity* (e.g., rosuvastatin 20‑40 mg) → ↓ LDL‑C ≥55 %. - **Clinical Benefits:** 20‑30 % relative risk reduction in major adverse cardiovascular events (MACE) per 1 mmol/L LDL‑C reduction; mortality benefit especially in secondary prevention. - **Safety Profile:** Most patients tolerate statins well. Routine monitoring of liver transaminases and creatine kinase is recommended at baseline and if symptoms arise. - **Contraindications/Precautions:** Active liver disease, pregnancy/lactation, known hypersensitivity, concomitant use of strong CYP3A4 inhibitors (e.g., clarithromycin) with certain statins. ## Significance Statins have transformed modern cardiology by shifting the paradigm from reactive treatment of heart attacks to proactive risk reduction. Their widespread use is estimated to have prevented millions of cardiovascular deaths worldwide, contributing to increased life expectancy in many high‑income nations. Economically, statins are cost‑effective, with generic formulations priced at a fraction of newer lipid‑lowering agents. Beyond cholesterol management, ongoing research explores statins’ role in neurodegenerative disease, cancer prevention, and immune modulation, reflecting their broad biological impact. Nonetheless, the “statin controversy”—fuelled by media reports of side effects—highlights the importance of balanced, evidence‑based communication. Health professionals must individualize therapy, weigh absolute risk reductions, and engage patients in shared decision‑making. **When to Seek Professional Care:** If you experience unexplained muscle pain, weakness, dark urine, persistent fatigue, or signs of liver dysfunction (e.g., jaundice, abdominal pain), contact your physician promptly. Do not discontinue statins without medical guidance, as abrupt cessation can increase cardiovascular risk. **INFOBOX:** - Name: **Statins (HMG‑CoA Reductase Inhibitors)** - Type: Lipid‑lowering pharmacologic agents - Date: First marketed 1987 (lovastatin) - Location: Global (widely prescribed in virtually all countries) - Known For: Reducing LDL‑cholesterol and preventing cardiovascular disease **TAGS:** cholesterol, cardiovascular disease, lipid‑lowering therapy, HMG‑CoA reductase inhibitors, pharmacology, preventive medicine, heart disease, clinical guidelines
Health & MedicineAngioplasty
Angioplasty is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries or veins, typically to treat arterial atherosclerosis.
Health & MedicineConditions Encyclopedia Entry 1775711285
Chronic Kidney Disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood, leading to a buildup of toxins and potential complications.
Health & MedicineMetabolic Syndrome
** Metabolic syndrome is a cluster of interrelated risk factors—abdominal obesity, elevated blood pressure, high fasting glucose, high triglycerides, and low HDL cholesterol—that together markedly increase the risk of cardiovascular disease, type 2 diabetes, and premature death. **CONTENT:** ## Overview Metabolic syndrome (MetS) describes a **multifactorial metabolic disturbance** in which three or more of five classic components coexist: **central (abdominal) obesity**, **elevated blood pressure**, **hyperglycemia**, **hypertriglyceridemia**, and **low high‑density lipoprotein (HDL) cholesterol**. The syndrome reflects underlying insulin resistance and chronic low‑grade inflammation, which together drive a cascade of vascular and metabolic damage. Individuals with MetS are two‑ to three‑fold more likely to develop atherosclerotic cardiovascular disease (ASCVD) and up to five‑fold more likely to progress to type 2 diabetes mellitus (T2DM). The diagnostic criteria differ slightly among major health organizations (e.g., the National Cholesterol Education Program Adult Treatment Panel III, the International Diabetes Federation), but all require the presence of at least three of the five risk factors. Because the components are modifiable, early identification offers a valuable window for lifestyle and pharmacologic interventions that can reverse or blunt disease progression. ## History/Background The concept of a “syndrome” linking obesity, hypertension, dyslipidemia, and glucose intolerance emerged in the 1970s when researchers noted a high prevalence of these abnormalities among patients with coronary artery disease. In 1988, **J. Reaven** coined the term **“Syndrome X”** to emphasize the central role of insulin resistance. The National Cholesterol Education Program (NCEP) formalized diagnostic thresholds in 2001 with the **Adult Treatment Panel III (ATP‑III)** guidelines, which remain widely used. The International Diabetes Federation (IDF) later refined the definition in 2005, adding ethnic‑specific waist‑circumference cut‑offs to improve global applicability. Over the past three decades, epidemiologic studies have shown a steady rise in MetS prevalence, paralleling worldwide increases in obesity and sedentary lifestyles. ## Key Information - **Diagnostic thresholds (ATP‑III):** 1. **Waist circumference** ≥ 102 cm (men) or ≥ 88 cm (women). 2. **Triglycerides** ≥ 150 mg/dL (1.7 mmol/L) or drug treatment. 3. **HDL‑C** < 40 mg/dL (men) or < 50 mg/dL (women) or drug treatment. 4. **Blood pressure** ≥ 130/85 mm Hg or antihypertensive therapy. 5. **Fasting glucose** ≥ 100 mg/dL (5.6 mmol/L) or glucose‑lowering medication. - **Pathophysiology:** Central obesity leads to excess free fatty acids and adipokine secretion, fostering insulin resistance. Insulin resistance impairs glucose uptake, raises hepatic VLDL production (raising triglycerides), and reduces HDL synthesis. Simultaneously, sympathetic overactivity and endothelial dysfunction raise blood pressure. - **Risk quantification:** The presence of MetS adds an estimated **20–30 % absolute increase** in 10‑year ASCVD risk beyond traditional calculators. - **Management:** First‑line therapy emphasizes **lifestyle modification**—weight loss of 5–10 % of body weight, ≥150 minutes/week of moderate‑intensity aerobic activity, and a Mediterranean‑style diet rich in fruits, vegetables, whole grains, nuts, and olive oil. Pharmacologic treatment targets individual components: statins for dyslipidemia, ACE inhibitors/ARBs for hypertension, metformin or newer agents (GLP‑1 receptor agonists, SGLT2 inhibitors) for hyperglycemia, and, when needed, fibrates or omega‑3 fatty acids for triglycerides. - **Screening recommendations:** Adults ≥ 20 years should be screened for waist circumference and fasting glucose at least every 3–5 years, with more frequent testing for those with overweight/obesity or a family history of diabetes or ASCVD. - **When to seek professional care:** If you notice rapid weight gain around the abdomen, persistent high blood pressure readings, fasting glucose ≥ 100 mg/dL, or abnormal lipid results on a routine blood test, schedule an appointment with a primary‑care provider. Early evaluation can prevent progression to heart attack, stroke, or diabetes. ## Significance Metabolic syndrome is a **public health priority** because it aggregates multiple modifiable risk factors into a single, high‑risk phenotype. Its rising prevalence—estimated at **20–30 % of adults in many high‑income countries** and climbing in low‑ and middle‑income nations—places a substantial burden on healthcare systems through increased hospitalizations, medication costs, and loss of productivity. Recognizing MetS shifts clinical focus from treating isolated abnormalities to addressing the **underlying insulin‑resistant state**, fostering more holistic preventive strategies. Moreover, research into the syndrome has spurred advances in understanding adipose tissue biology, the gut‑microbiome’s role in metabolism, and the therapeutic potential of novel agents that improve insulin sensitivity and cardiovascular outcomes. By integrating lifestyle counseling, risk‑factor‑specific drugs, and emerging therapies, clinicians can markedly reduce the long‑term complications associated with MetS, underscoring the importance of early detection and sustained management. **INFOBOX:** - **Name:** Metabolic Syndrome (also known as Syndrome X or Insulin‑Resistance Syndrome) - **Type:** Clinical syndrome / metabolic disorder - **Date:** First described as “Syndrome X” in 1988; formal diagnostic criteria established 2001 (ATP‑III) - **Location:** Global (prevalence varies by region, ethnicity, and socioeconomic status) - **Known For:** Clustering of abdominal obesity, hypertension, hyperglycemia, hypertriglyceridemia, and low HDL cholesterol, markedly increasing cardiovascular and diabetes risk **TAGS:** metabolic syndrome, insulin resistance, cardiovascular disease, type 2 diabetes, obesity, hypertension, dyslipidemia, public health
Health & MedicineConditions Encyclopedia Entry 1775869928
** This article provides an in-depth look at **Hyperthyroidism**, a medical condition characterized by an overactive thyroid gland, leading to excessive production of thyroid hormones. ## Overview Hyperthyroidism is a condition where the thyroid gland produces too many thyroid hormones, leading to an overactive metabolism. This can cause a range of symptoms, including weight loss, rapid heartbeat, nervousness, and fatigue. In most cases, hyperthyroidism is caused by an autoimmune disorder, where the immune system mistakenly attacks the thyroid gland, leading to inflammation and increased hormone production. However, other causes can include thyroid nodules, thyroiditis, or excessive iodine intake. Hyperthyroidism can be caused by several factors, including: - **Graves' disease**: an autoimmune disorder where the immune system produces antibodies that stimulate the thyroid gland to produce excess hormones. - **Thyroid nodules**: abnormal growths on the thyroid gland that can produce excess hormones. - **Thyroiditis**: inflammation of the thyroid gland, which can lead to the release of stored hormones into the bloodstream. - **Excessive iodine intake**: consuming too much iodine can stimulate the thyroid gland to produce excess hormones. ## History/Background Hyperthyroidism has been recognized as a medical condition for centuries. The ancient Greeks and Romans described symptoms of hyperthyroidism, including weight loss and rapid heartbeat. In the 19th century, the French physician Jean-Martin Charcot described a condition called "basedow's disease," which is now known as Graves' disease. The first successful treatment for hyperthyroidism was the development of **surgery** in the late 19th century. Surgeons began to remove the thyroid gland to treat the condition. However, this was a major operation that carried significant risks. In the 20th century, the development of **radiation therapy** and **medications** provided alternative treatments for hyperthyroidism. ## Key Information Hyperthyroidism can be diagnosed through a combination of physical examination, medical history, and laboratory tests. These tests may include: - **Thyroid function tests**: measure the levels of thyroid hormones in the blood. - **Thyroid-stimulating hormone (TSH) test**: measures the level of TSH in the blood, which stimulates the thyroid gland to produce hormones. - **Radioactive iodine uptake test**: measures the amount of radioactive iodine absorbed by the thyroid gland. Treatment for hyperthyroidism depends on the underlying cause and severity of the condition. Options may include: - **Medications**: such as beta blockers and antithyroid medications to reduce hormone production. - **Radiation therapy**: to destroy part of the thyroid gland. - **Surgery**: to remove part or all of the thyroid gland. - **Radioactive iodine**: to destroy part of the thyroid gland. ## Significance Hyperthyroidism can have significant consequences if left untreated. Excessive thyroid hormone production can lead to: - **Cardiovascular disease**: increased risk of heart attack and stroke. - **Osteoporosis**: weakened bones due to excessive thyroid hormone production. - **Eye problems**: bulging eyes and vision problems due to Graves' disease. Early diagnosis and treatment of hyperthyroidism can prevent these complications and improve quality of life. INFOBOX: - Name: Hyperthyroidism - Type: Endocrine disorder - Date: Recognized as a medical condition for centuries - Location: Global - Known For: Excessive production of thyroid hormones TAGS: Hyperthyroidism, thyroid gland, Graves' disease, thyroid nodules, thyroiditis, excessive iodine intake, autoimmune disorder, endocrine disorder, cardiovascular disease, osteoporosis, eye problems.
Health & MedicineCardiac Surgery
** Cardiac surgery is a specialized field of operative medicine that repairs or replaces structures of the heart and great vessels to treat life‑threatening cardiovascular disease. **CONTENT:** ## Overview Cardiac surgery, also called **cardiovascular surgery**, encompasses any operative procedure performed on the heart itself or the major vessels attached to it. Modern cardiac surgeons employ a range of techniques—from traditional **open‑heart surgery** with cardiopulmonary bypass to minimally invasive and robot‑assisted approaches—to address conditions such as **ischemic heart disease**, **congenital heart defects**, and **valvular heart disease** caused by infection, rheumatic fever, or atherosclerosis. The ultimate goal is to restore adequate blood flow, correct structural abnormalities, and improve long‑term survival and quality of life. Because the heart is a vital organ that cannot be stopped for long periods, most procedures require sophisticated equipment, including a heart‑lung machine that temporarily takes over circulation and oxygenation. In recent decades, advances such as **off‑pump coronary artery bypass grafting (OPCAB)**, **transcatheter aortic valve replacement (TAVR)**, and **hybrid operating rooms** have expanded the therapeutic armamentarium, allowing many patients to avoid full sternotomy and prolonged recovery. Nevertheless, any cardiac operation carries inherent risks—bleeding, infection, arrhythmias, stroke, and organ dysfunction—so patients should always discuss the benefits and alternatives with a qualified cardiac surgeon and seek immediate medical attention for any postoperative warning signs (e.g., chest pain, shortness of breath, fever, or wound drainage). ## History/Background The roots of cardiac surgery trace back to the early 19th century, when surgeons such as **Ludwig Rehn** performed the first successful **intracardiac repair** (a ventricular wound) in 1896. The field truly accelerated after **John Gibbon** introduced the first practical **cardiopulmonary bypass (CPB) machine** in 1953, enabling surgeons to stop the heart safely for complex repairs. The landmark operation by **C. Walton Lillehei** in 1954—performing the first successful **cross‑clamp** repair of a ventricular septal defect—demonstrated that the heart could be opened and reconstructed. The 1960s saw the birth of **coronary artery bypass grafting (CABG)**, pioneered by **Vidal** and **Favaloro**, which remains a cornerstone for treating coronary artery disease. The first **heart transplant** was performed by **Christiaan Barnard** in 1967, opening a new era of organ replacement. Throughout the 1970s and 1980s, improvements in CPB circuitry, myocardial protection (e.g., cardioplegia), and postoperative care reduced mortality dramatically—from >30 % in the 1950s to <5 % by the 1990s. The 21st century has been defined by **minimally invasive** and **percutaneous** techniques, such as **TAVR** (first FDA approval in 2011) and **robotic mitral valve repair**, which broaden eligibility to older and higher‑risk patients. ## Key Information - **Procedural categories:** - *Coronary revascularization* (CABG, OPCAB, hybrid PCI‑CABG). - *Valve surgery* (aortic, mitral, tricuspid repair or replacement; mechanical vs. bioprosthetic valves). - *Congenital repairs* (tetralogy of Fallot, atrial septal defect closure, Fontan procedure). - *Aortic surgery* (ascending aortic aneurysm repair, dissection repair, endovascular stent grafting). - *Transplantation* (orthotopic heart transplant, ventricular assist device implantation). - **Technological advances:** - **Off‑pump** techniques reduce inflammatory response and neurocognitive complications. - **Hybrid operating rooms** combine surgical and catheter‑based tools for simultaneous procedures. - **Robotics** (e.g., Da Vinci system) enable precise, small‑incision valve repairs. - **3‑D printing** of patient‑specific cardiac models assists pre‑operative planning. - **Outcomes:** Modern centers report 30‑day mortality rates of 1–3 % for isolated CABG and 2–5 % for valve replacements, with median survival extending beyond 10 years for most elective cases. - **Risks & postoperative care:** Common complications include atrial fibrillation, wound infection, renal insufficiency, and postoperative cognitive decline. Early mobilization, strict glycemic control, and adherence to anticoagulation regimens (especially for mechanical valves) are critical. Patients should promptly contact their surgical team if they experience chest discomfort, palpitations, fever, or swelling at the incision site. ## Significance Cardiac surgery has transformed cardiovascular disease from an often fatal condition into a manageable chronic illness for millions worldwide. By restoring blood flow to the myocardium, repairing defective valves, and correcting congenital malformations, these operations dramatically reduce mortality, alleviate symptoms, and enable patients to return to productive lives. The field also drives innovation in biomedical engineering, perfusion science, and critical care, influencing disciplines far beyond the operating theater. Moreover, the success of heart transplantation and mechanical circulatory support has paved the way for organ‑replacement strategies in other systems. As the global burden of heart disease rises with aging populations, cardiac surgery remains a cornerstone of modern health care, underscoring the importance of continued research, training, and equitable access to these life‑saving procedures. **INFOBOX:** - Name: Cardiac Surgery (Cardiovascular Surgery) - Type: Surgical specialty within medicine - Date: Modern era began 1953 (introduction of cardiopulmonary bypass) - Location: Performed worldwide in tertiary hospitals and specialized cardiac centers - Known For: Restoring coronary blood flow, repairing heart valves, correcting congenital defects, and performing heart transplantation **TAGS:** cardiac surgery, cardiovascular disease, coronary artery bypass, valve replacement, heart transplantation, congenital heart defect, minimally invasive surgery, cardiopulmonary bypass
Health & MedicineCardiac Rehabilitation
Cardiac rehabilitation (CR) is a comprehensive model of care that aims to improve the quality of life and reduce the risk of future heart problems for patients with chronic or post-acute cardiovascular disease. ## Overview Cardiac rehabilitation (CR) is a multidisciplinary program that provides a structured approach to helping patients recover from heart disease, heart failure, or other cardiovascular conditions. The program is designed to address the physical, emotional, and social aspects of heart disease, with the ultimate goal of enabling patients to lead an active and healthy life. CR is typically offered to patients who have undergone a heart attack, coronary artery bypass grafting (CABG), angioplasty, or other cardiac procedures. The CR program is tailored to meet the individual needs of each patient, taking into account their medical history, physical abilities, and personal goals. A team of healthcare professionals, including cardiologists, nurses, physical therapists, dietitians, and psychologists, work together to provide a comprehensive approach to CR. The program typically includes a combination of exercise, education, and counseling, with a focus on lifestyle modifications and risk factor reduction. ## History/Background The concept of CR dates back to the 1950s, when cardiologists began to recognize the importance of exercise and lifestyle modifications in the management of heart disease. In the 1960s and 1970s, CR programs began to emerge in the United States and Europe, with a focus on exercise and education. The American Heart Association (AHA) played a significant role in promoting CR, and in 1971, the AHA established the first CR program in the United States. In 1985, the AHA published its first guidelines for CR, which emphasized the importance of a multidisciplinary approach to care. The World Health Organization (WHO) also recognized the importance of CR, and in 2000, the WHO defined CR as "the sum of activity and interventions required to ensure the best possible physical, mental, and social conditions so that patients with chronic or post-acute cardiovascular disease may, by their own efforts, preserve or resume their proper place in society and lead an active life." ## Key Information Key components of CR include: * **Structured exercise**: A supervised exercise program that includes aerobic exercise, strength training, and flexibility exercises. * **Patient education**: Education on heart disease, risk factor reduction, and lifestyle modifications. * **Psychosocial counseling**: Counseling to address emotional and social aspects of heart disease. * **Risk factor reduction**: Strategies to reduce risk factors such as hypertension, hyperlipidemia, and diabetes. * **Behavior modification**: Techniques to promote healthy behaviors and lifestyle changes. Studies have consistently shown that CR can improve cardiovascular outcomes, including reduced mortality, improved quality of life, and reduced risk of future heart problems. CR has also been shown to be cost-effective and can reduce healthcare costs associated with heart disease. ## Significance Cardiac rehabilitation is a critical component of heart disease management, and its significance cannot be overstated. By providing a comprehensive approach to care, CR can improve patient outcomes, reduce healthcare costs, and enhance quality of life. The WHO has recognized CR as an essential component of cardiovascular care, and it is now an integral part of heart disease management worldwide. INFOBOX: - Name: Cardiac Rehabilitation - Type: Multidisciplinary program - Date: 1950s (concept emerged) - Location: Global - Known For: Improving cardiovascular outcomes and reducing risk of future heart problems TAGS: Cardiac rehabilitation, heart disease, cardiovascular disease, exercise, education, counseling, risk factor reduction, behavior modification, quality of life, mortality, healthcare costs.
Health & MedicineConditions Encyclopedia Entry 1777167188
Atrial Septal Defect (ASD) is a congenital heart defect characterized by an abnormal opening in the wall (septum) between the heart's two upper chambers (atria), allowing blood to flow between them.
Health & MedicineConditions Encyclopedia Entry 1777913285
Ehlers-Danlos Syndrome (EDS) is a group of genetic disorders that affect the body's connective tissue, leading to fragile skin, joints, and blood vessels.
Health & MedicineConditions Encyclopedia Entry 1779106624
This encyclopedia entry provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management and treatment.
Health & MedicineConditions Encyclopedia Entry 1780261505
Ehlers-Danlos Syndrome (EDS) is a group of genetic disorders affecting the body's connective tissue, leading to fragile skin, joints, and blood vessels.
Health & MedicineConditions Encyclopedia Entry 1780002965
Klinefelter syndrome is a genetic condition that affects males, characterized by the presence of an extra X chromosome, leading to physical and developmental differences.
Health & MedicineConditions Encyclopedia Entry 1782450966
Klinefelter syndrome is a genetic disorder that affects males, characterized by the presence of an extra X chromosome, leading to various physical, developmental, and reproductive issues.
Health & MedicineConditions Encyclopedia Entry 1781402825
** This encyclopedia entry is about **Rheumatoid Arthritis (RA)**, a chronic autoimmune disorder that affects the joints and surrounding tissues. **CONTENT:** ## Overview Rheumatoid Arthritis (RA) is a complex and debilitating condition that affects millions of people worldwide. It is a chronic autoimmune disorder that causes inflammation and pain in the joints, leading to stiffness, swelling, and eventually, joint damage and deformity. RA is a systemic disease, meaning it can affect not only the joints but also other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. In this entry, we will explore the history, key information, and significance of RA, as well as provide an overview of the condition. RA is characterized by the presence of autoantibodies, specifically rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs), which are produced by the immune system and attack the lining of the joints, leading to inflammation and joint damage. The exact cause of RA is still unknown, but it is believed to result from a combination of genetic and environmental factors. ## History/Background The first recorded description of RA dates back to 1800 BCE, in the Ebers Papyrus, an ancient Egyptian medical text. However, it was not until the 19th century that RA was formally described as a distinct medical condition. In 1800, the British physician William Hey first described a case of RA, and in 1859, the French physician Alfred Bouchard coined the term "rheumatoid arthritis." Over the years, our understanding of RA has evolved significantly, and it is now recognized as a complex autoimmune disorder that requires a comprehensive treatment approach. ## Key Information * **Prevalence:** RA affects approximately 1% of the global population, with women being more likely to develop the condition than men. * **Symptoms:** Common symptoms of RA include joint pain and stiffness, swelling, redness, and warmth, as well as fatigue, fever, and loss of appetite. * **Diagnosis:** RA is diagnosed based on a combination of clinical evaluation, laboratory tests (such as RF and ACPA tests), and imaging studies (such as X-rays and MRI scans). * **Treatment:** Treatment for RA typically involves a combination of medications, including disease-modifying antirheumatic drugs (DMARDs), biologics, and corticosteroids, as well as lifestyle modifications, such as exercise and stress management. * **Complications:** Untreated or poorly managed RA can lead to serious complications, including joint deformity, osteoporosis, and cardiovascular disease. ## Significance RA is a significant public health concern, with a substantial impact on quality of life, productivity, and healthcare costs. According to the World Health Organization (WHO), RA is one of the top 10 leading causes of disability worldwide. In addition, RA is associated with an increased risk of cardiovascular disease, osteoporosis, and other comorbidities, making early diagnosis and treatment crucial for preventing long-term complications. **INFOBOX:** - **Name:** Rheumatoid Arthritis (RA) - **Type:** Chronic autoimmune disorder - **Date:** 1800 BCE (first recorded description) - **Location:** Global - **Known For:** Chronic joint inflammation and pain, leading to joint damage and deformity **TAGS:** Rheumatoid Arthritis, autoimmune disorder, chronic disease, joint inflammation, pain management, disease-modifying antirheumatic drugs (DMARDs), biologics, corticosteroids, quality of life, public health concern, disability, cardiovascular disease, osteoporosis.
Health & MedicineConditions Encyclopedia Entry 1780103901
** This entry is about **Atherosclerosis**, a chronic and progressive condition characterized by the buildup of plaque in the arteries, leading to cardiovascular disease and other complications. **CONTENT:** ### Overview Atherosclerosis is a widespread and complex condition that affects millions of people worldwide. It is a chronic and progressive disease in which the arteries become narrowed and hardened due to the accumulation of plaque, a mixture of fat, cholesterol, and other substances. This buildup, known as atherosclerotic plaque, can lead to the formation of blood clots, which can cause heart attacks, strokes, and other cardiovascular events. Atherosclerosis is a leading cause of morbidity and mortality globally, and its management is a critical aspect of cardiovascular medicine. Atherosclerosis can affect any artery in the body, but it most commonly affects the coronary arteries, which supply blood to the heart muscle. When the coronary arteries become narrowed or blocked, it can lead to chest pain, shortness of breath, and other symptoms of angina. In severe cases, atherosclerosis can cause a heart attack, which can be fatal if not treated promptly. ### History/Background The concept of atherosclerosis dates back to ancient civilizations, with descriptions of hardened arteries found in the works of Hippocrates and Galen. However, it was not until the 19th century that the condition was formally described and studied. In 1852, the German pathologist Rudolf Virchow described the characteristic changes in the arteries of individuals with atherosclerosis, including the buildup of plaque and the formation of blood clots. In the 20th century, the understanding of atherosclerosis underwent significant advances with the discovery of the role of cholesterol in the development of the condition. The work of scientists such as Ancel Keys and Nathan Pritikin led to a greater understanding of the relationship between diet, lifestyle, and atherosclerosis. Today, atherosclerosis is recognized as a multifactorial disease, influenced by a combination of genetic, environmental, and lifestyle factors. ### Key Information Atherosclerosis is characterized by the following key features: * **Plaque buildup**: The accumulation of fat, cholesterol, and other substances in the arteries, leading to the formation of atherosclerotic plaque. * **Inflammation**: The activation of immune cells and the release of pro-inflammatory cytokines, which contribute to the development and progression of atherosclerosis. * **Blood clot formation**: The formation of blood clots, which can cause cardiovascular events such as heart attacks and strokes. * **Narrowing and hardening of arteries**: The reduction in the diameter of the arteries and the increase in their stiffness, leading to reduced blood flow and increased blood pressure. Risk factors for atherosclerosis include: * **High blood pressure**: Elevated blood pressure can damage the arteries and increase the risk of atherosclerosis. * **High cholesterol**: Elevated levels of low-density lipoprotein (LDL) cholesterol can contribute to the development of atherosclerosis. * **Smoking**: Smoking can damage the arteries and increase the risk of atherosclerosis. * **Diabetes**: Individuals with diabetes are at increased risk of developing atherosclerosis. * **Family history**: A family history of atherosclerosis or cardiovascular disease can increase an individual's risk. ### Significance Atherosclerosis is a significant public health concern, with millions of people worldwide affected by the condition. The management of atherosclerosis is critical to preventing cardiovascular events and reducing mortality. Lifestyle modifications, such as a healthy diet and regular exercise, can help to reduce the risk of atherosclerosis. Medications, such as statins and blood thinners, can help to manage the condition and prevent complications. **INFOBOX:** - Name: Atherosclerosis - Type: Cardiovascular disease - Date: 1852 (first formal description) - Location: Global - Known For: Chronic and progressive condition characterized by the buildup of plaque in the arteries. **TAGS:** Atherosclerosis, cardiovascular disease, plaque buildup, inflammation, blood clot formation, narrowing and hardening of arteries, high blood pressure, high cholesterol, smoking, diabetes, family history.
Health & MedicineConditions Encyclopedia Entry 1778940498
Chronic Kidney Disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood, potentially leading to kidney failure if left untreated.
Health & MedicineConditions Encyclopedia Entry 1778047397
Klinefelter syndrome is a genetic disorder that affects males, characterized by the presence of an extra X chromosome, leading to physical and developmental abnormalities.